Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Pegilodecakin |
| Trade Name | |
| Synonyms | AM0010|AM-0010 |
| Drug Descriptions |
Pegilodecakin (AM0010) is recombinant human interleukin-10 (IL-10) conjugated with polyethylene glycol (PEG), which may induce anti-tumor immune response (J Clin Oncol 34, 2016 (suppl; abstr 3082), PMID: 31706853, PMID: 31563517). |
| DrugClasses | |
| CAS Registry Number | 1966111-35-2 |
| NCIT ID | C113295 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Capecitabine + Pegilodecakin | Capecitabine Pegilodecakin | 0 | 0 |
| Fluorouracil + Leucovorin + Oxaliplatin + Pegilodecakin | Fluorouracil Leucovorin Oxaliplatin Pegilodecakin | 0 | 1 |
| Nivolumab + Pegilodecakin | Nivolumab Pegilodecakin | 0 | 1 |
| Pegilodecakin | Pegilodecakin | 0 | 1 |
| Pegilodecakin + Pembrolizumab | Pegilodecakin Pembrolizumab | 0 | 1 |